Atopic Dermatitis

SAN DIEGO — In children aged 2 to 5 years with atopic dermatitis, roflumilast cream 0.05% significantly improved symptoms compared with vehicle, with improvement seen as early as 1 week after treatment, according to a speaker here.

SAN DIEGO — New data showed Vtama cream achieved consistent and strong efficacy for the treatment of atopic dermatitis across all racial groups, according to a poster presentation at the 2024 American Academy of Dermatology Annual Meeting.

WASHINGTON — The most effective treatments for atopic dermatitis may also be the most harmful, according to a study presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Arcutis has entered into a licensing agreement with Sato Pharmaceutical Co. Ltd. to develop, manufacture and commercialize topical roflumilast in Japan for the treatment of multiple skin conditions, according to a company press release.

The efficacy of tapinarof cream 1% has validated the aryl hydrocarbon receptor as a therapeutic target for the treatment of atopic dermatitis, according to a study.

WASHINGTON — Atopic dermatitis can be predicted in children aged as young as 6 months with skin microbiome and metabolome signatures, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — Ruxolitinib was efficacious and well tolerated in pediatric patients with mild to moderate atopic dermatitis, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — Patients with moderate to severe atopic dermatitis treated with lebrikizumab maintained improvements in patient-reported outcomes, according to a poster presented here.

WASHINGTON — Patients with atopic dermatitis may have better outcomes when using liquid synthetic detergents, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.